Session Details
[LS-37]Luncheon Seminar 37 Should we start MAOB inhibitor therapy with monotherapy or in combination with levodopa ?
Fri. May 23, 2025 12:00 PM - 1:00 PM JST
Fri. May 23, 2025 3:00 AM - 4:00 AM UTC
Fri. May 23, 2025 3:00 AM - 4:00 AM UTC
第11会場(大阪国際会議場8F 会議室801-802)
Chair: Takanori Hazama（Department of Neurology, National Hospital Organization Osaka Minami Medical Center, Japan）
Sponsored by: FP Pharmaceutical Corporation
[LS-37-1]MAO-B inhibitors as adjunctive therapy to L-dopa in early Parkinson’s disease
Tetsuya Maeda (Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Japan)
[LS-37-2]MAO-B inhibitors as monotherapy in early Parkinson's disease
Hiroshi Nagayama (NTT Medical Center Tokyo Department of Neurology, Japan)